These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 515108)

  • 21. [Drug decomposition kinetics. XLIX. Kinetics of auto-oxidation of drotaverine hydrochloride in the solid phase].
    Pawełczyk E; Opielewicz M
    Acta Pol Pharm; 1978; 35(3):311-9. PubMed ID: 696363
    [No Abstract]   [Full Text] [Related]  

  • 22. Vasospasm.
    Agrawal D
    J Neurosurg; 2002 Feb; 96(2):382-3. PubMed ID: 11838817
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of prostaglandins and drotaverine on ADP-induced platelet aggregation.
    Losonczy H; Nagy I; Gregus Z
    Acta Med Acad Sci Hung; 1974; 31(3-4):157-63. PubMed ID: 4469713
    [No Abstract]   [Full Text] [Related]  

  • 24. Study of drotaverine on first stage of labour and pregnancy outcome.
    Roy A; Patra KK; Mukhopadhyay S; Guha S
    J Indian Med Assoc; 2007 Aug; 105(8):450, 452. PubMed ID: 18236908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Computer simulation of blood level profiles. Drug liberation from two sustained-release preparations and computer simulation of single- and multiple-dose pharmacokinetics].
    Koch HP
    Pharmazie; 1992 Jul; 47(7):547-52. PubMed ID: 1518902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Research and development of oral controlled-release dosage forms].
    Moës AJ
    J Pharm Belg; 1989; 44(1):60-70. PubMed ID: 2656982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sustained-release pellet of vasodilators--basic experiment].
    Okumura T; Oda Y; Arimitsu T; Mori K
    No Shinkei Geka; 1984 Oct; 12(11):1265-71. PubMed ID: 6514125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The time to reach steady state after the administration of intravenous bolus, constant infusion, and oral immediate-release and sustained-release preparations.
    Chow MS; Sun H
    Pharmacotherapy; 1990; 10(6):400-5. PubMed ID: 2287561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative pharmacokinetics and relative bioavailability for different preparations of nitrofurantoin.
    Maier-Lenz H; Ringwelski L; Windorfer A
    Arzneimittelforschung; 1979; 29(12):1898-901. PubMed ID: 583541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of mepacrine on gastric motility in the rat.
    Minker E; Matejka Z
    Acta Physiol Acad Sci Hung; 1979; 53(3):369-75. PubMed ID: 543402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sustained release papaverine in peripheral ischemia: report of 21 ambulatory cases with oscillometric studies.
    Tibbs EE
    South Med J; 1969 Jul; 62(7):875-8. PubMed ID: 5790687
    [No Abstract]   [Full Text] [Related]  

  • 32. Haemodynamic responses to drotaverine and noradrenaline in the dog.
    Pogátsa G; Dubecz E; Gábor G
    Acta Med Acad Sci Hung; 1974; 31(3-4):139-45. PubMed ID: 4469711
    [No Abstract]   [Full Text] [Related]  

  • 33. [Practical significance of drug equivalence in preclinical research, with special reference to drotaverin and its salt with theophylline-7-acetic acid].
    Szentmiklósi P; Marton S
    Acta Pharm Hung; 1979 Mar; 49(2):50-3. PubMed ID: 582086
    [No Abstract]   [Full Text] [Related]  

  • 34. Simultaneous determination of nifuroxazide and drotaverine hydrochloride in pharmaceutical preparations by bivariate and multivariate spectral analysis.
    Metwally FH
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Feb; 69(2):343-9. PubMed ID: 17631041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A method of determining the in vivo drug release rate constant of sustained-release preparation.
    Sun H; Chow MS
    Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Human data on the metabolism and pharmacokinetics of an analog of papaverine: 6,7-dimethoxy-4-(4-chlorobenzyl)-4-isoquinoline].
    Lussiana JP; Jacquot C; Plat M; Viel C
    Ann Pharm Fr; 1983; 41(2):151-8. PubMed ID: 6651163
    [No Abstract]   [Full Text] [Related]  

  • 37. Novel sustained release microspheres for pulmonary drug delivery.
    Cook RO; Pannu RK; Kellaway IW
    J Control Release; 2005 May; 104(1):79-90. PubMed ID: 15866336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the characteristics of oral dosage forms with release controlled by erosion.
    Rosca ID; Vergnaud JM
    Comput Biol Med; 2008 Jun; 38(6):668-75. PubMed ID: 18455158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advances in research on in vivo-in vitro correlation of sustained-release oral dosage forms in traditional Chinese medicine].
    Chen LH; Xu DS; Feng Y
    Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):333-8. PubMed ID: 18536476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.